Advertisement

Folate metabolism and neural tube defects

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Neural tube defects may due to a number of factors acting on a susceptible embryo. The most widely accepted is a lack of folic acid at a critical time of development. Studies in which folic acid supplements have been given are reviewed. The results of these support the policy of giving folic acid, starting before conception.
      The metabolism of folate and vitamin B12 is discussed, including specific metabolic disorders; although there is no evidence that these play any part in causing neural tube defects. The special problems that occur among women taking anti-epileptic drugs are also considered.
      There are slight differences in the recommendations that have been made for supplementation, and further studies are needed before there can be complete agreement.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Carter C.O.
        Clues to the aetiology of neural tube malformations.
        Dev Med Child Neurol. 1974; 16: 3-15
        • Stone D.H.
        The declining prevalence of anencephalus and spina bifida: its nature, causes and implications.
        Dev Med Child Neurol. 1987; 29: 541-549
        • Smithells R.W.
        • Sheppard S.
        • Schorah C.J.
        • et al.
        Possible prevention of neural tube defects by periconceptional vitamin supplementation.
        Lancet. 1980; i: 339-340
        • Brett E.M.
        Paediatric neurology.
        in: 2nd edn. Churchill Livingstone, Edinburgh1991: 463
        • Menkes J.H.
        4th edn. Textbook of child neurology. Lea & Febiger, Philadelphia1990: 216
        • Smithells R.W.
        • Sheppard S.
        • Schorah C.J.
        • et al.
        Apparent prevention of neural tube defects by periconceptional vitamin supplementation.
        Arch Dis Child. 1981; 56: 911-918
        • Smithells R.W.
        • Nevin N.C.
        • Seller M.J.
        • et al.
        Further experience of vitamin supplementation for prevention of neural tube defect recurrences.
        Lancet. 1983; i: 1027-1031
        • Czeizel A.E.
        Prevention of congenital abnormalities by periconceptional multivitamin supplementation.
        Br Med J. 1993; 306: 1645-1648
        • Kirke P.N.
        • Daly L.E.
        • Elwood J.H.
        A randomised trial of low dose folic acid to prevent neural tube defects.
        Arch Dis Child. 1992; 67: 1442-1446
        • Willett W.C.
        Folic acid and neural tube defect: can't we come to closure.
        Am J Publ. Health. 1992; 82: 666-668
        • Milunski A.
        • Jick S.
        • Jick S.S.
        • et al.
        Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.
        JAMA. 1989; 262: 2847-2852
        • Mills J.L.
        • Rhoads G.G.
        • Simpson J.L.
        • et al.
        The absence of a relation between the periconceptual use of vitamins and neuraltube defects.
        N Engl J Med. 1989; 321: 430-435
        • Mills J.L.
        • Tuomilehto J.
        • Yu K.F.
        • et al.
        Maternal vitamin levels during pregnancies producing infants with neural tube defects.
        J Pediatr. 1992; 120: 863-874
        • Lorber J.
        • Ward A.M.
        Spina bifida — a vanishing nightmare?.
        Arch Dis Child. 1985; 60: 1086-1091
        • Yen I.H.
        • Khoury M.J.
        • Erickson J.D.
        • James L.M.
        • Waters G.D.
        • Berry R.J.
        The changing epidemiology of neural tube defects.
        Am J Dis Child. 1992; 746: 857-861
        • Copp A.J.
        Birth defects: from molecules to mechanisms.
        J R Coll Physicians Lond. 1994; 28: 294-300
        • Yates J.R.W.
        • Ferguson-Smith M.A.
        • Shenkin A.
        • Guzman-Rodriguez R.
        • White M.
        • Clark B.J.
        Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects?.
        Clin Genet. 1987; 31: 279-287
        • Wild J.
        • Seller M.J.
        • Schorah C.J.
        • Smithells R.W.
        Investigation of folate intake and metabolism in women who have had two pregnancies complicated by neural tube defects.
        Br J Obstet Gynaecol. 1994; 101: 197-202
        • Wild J.
        • Schorah C.J.
        • Sheldon T.A.
        • Smithells R.W.
        Investigation of factors influencing folate status in women who have had a neural tube defect-affected infant.
        Br J Obstet Gynaecol. 1993; 100: 456-459
        • Mooij P.N.M.
        • Steegers-Theunissen R.P.M.
        • Thomas C.M.G.
        • Doesburg W.H.
        • Eskes T.K.A.B.
        Periconceptional vitamin profiles are not suitable for identifying women at risk for neural tube defects.
        J Nutr. 1993; 123: 197-203
        • Bower C.
        • Stanley F.J.
        • Croft M.
        • De Klerk N.H.
        • Davis R.E.
        • Nicol D.J.
        Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects.
        Br J Nutr. 1993; 69: 827-834
        • Gardiki-Kouidou P.
        • Seller M.J.
        Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects.
        Clin Genet. 1988; 33: 441-448
        • Mills L.J.
        • McPartlin J.M.
        • Kirke P.N.
        • Lee Y.L.
        • Conley M.R.
        • Weir D.G.
        Homocysteine metabolism in pregnancies complicated by neural-tube defects.
        Lancet. 1995; 345: 149-151
        • Erbe R.W.
        Inborn errors of folate metabolism.
        N Engl J Med. 1971; 293: 753-757
        • Erbe R.W.
        Inborn errors of folate metabolism.
        N Engl J Med. 1971; 293: 807-812
        • Corbeel L.
        • Van den Berhge G.
        • Jacken J.
        • Van Tornout J.
        • Eekels R.
        Congenital folate malabsorption.
        Eur J Pediatr. 1985; 143: 284-290
        • Danski L.V.
        • Rosenblatt D.S.
        • Andermann E.
        Mechanisms of teratogenesis: folic acid and epileptic therapy.
        Neurology. 1992; 42: 32-42
        • Urbach J.
        • Abrahamov A.
        • Grossowicz N.
        Congenital isolated folic acid malabsorption.
        Arch Dis Child. 1987; 62: 78-80
        • Girling J.C.
        • Shennan A.H.
        Epilepsy and pregnancy.
        Br Med J. 1993; 307: 937
        • Nelson-Piercy C.
        Pre-pregnancy counselling.
        Maternal Child Health. 1994; 19: 254-258
        • Elmazar M.M.A.
        • Nau H.
        Trimethoprim potentiates valproic acid-induced neural tube defects (NTDs) in mice.
        Reprod Toxicol. 1993; 7: 249-254
        • Wegner C.
        • Nau H.
        Alteration of embryonic folate metabolism by valproic acid during organogenesis.
        Neurology. 1992; 42: 17-24
        • O'Brien M.D.
        • Gilmour-White S.
        Epilepsy and pregnancy.
        Br Med J. 1993; 307: 492-495
        • Hubert H.
        The history of the Celtic people.
        Bracken Books, London1993
        • Seller M.J.
        Risks in spina bifida.
        Dev Med Child Neurol. 1994; 36: 1021-1025
        • Habibzadeh N.
        • Schorah C.J.
        • Seller M.J.
        • Smithells R.W.
        • Levene M.I.
        Uptake and utilization of DL-5-methyl-14Ctetrahydropteroylmonoglutamate by cultured cytotrophoblasts associated with neural tube defects.
        in: 2nd edn. Proc Soc Exp Biol Med. 203. 1993: 45-54
        • Mortimer E.A.
        The puzzling epidemiology of neural tube defects.
        Pediatrics. 1980; 65: 636-638
      1. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.
        Lancet. 1991; 338 (MRC Vitamin Study Research Group): 131-137
        • Werler M.M.
        • Shapiro S.
        • Mitchell A.A.
        Periconceptional folic acid exposure and risk of occurrent neural tube defects.
        JAMA. 1993; 269: 1257-1261
        • Rush D.
        Periconceptional folate and neural tube defect.
        Am J Clin Nutr. 1994; 59 (Suppl): 5115-5165
        • Kirke P.N.
        • Molloy A.M.
        • Daly A.E.
        • Burke H.
        • Weir D.G.
        • Scott J.M.
        Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects.
        Q J Med. 1993; 86: 703-708
        • Steegers-Theunissen R.P.M.
        • Boers G.H.J.
        • Trijbels F.J.M.
        • Eskes T.K.A.B.
        Neural-tube defects and derangement of homocysteine metabolism.
        N Engl J Med. 1991; 324: 199-200
        • Van Allen M.I.
        • Clark Fraser F.
        • Dallaire L.
        • et al.
        Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects.
        Can Med Assoc J. 1993; 149: 1239-1243
        • Czeizel A.E.
        • Dud S.I.
        Prevention of first occurrence of neural-tube defects by periconceptional vitamin supplementation.
        N Engl J Med. 1992; 327: 1832-1835
        • Bower C.
        • Raymond M.
        • Lumley J.
        • Bury G.
        Trends in neural tube defects 1980–1989.
        Med J Aust. 1993; 158: 152-154